Eirion
PrivateLast Round
Series A
Mar 9, 2021
Total Funding Raised
$32M
Company Overview
Eirion is a pharmaceutical company specializing in prescription products for aesthetic dermatology, offering solutions for wrinkles, hyperhidrosis, hair loss, and greying hair to help patients address various skin and hair concerns.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Clinical Trials, Fashion & Beauty
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Eirion Comps
Public and private peers based on sector, stage, and business model.
Eirion Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 9, 2021 |
Eirion Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Gore Range Capital | Series A |
| Kinled Holding | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 1, 2025
Will present at the Society for Investigative Dermatology 2025 annual meeting.
Eirion Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Eirion's valuation, stock price, and market status.
